Contribution of Plasma Protease Inhibitors to the Inactivation of Kallikrein in Plasma
Although C̄l-inhibitor (C̄l-INH) and α(2)-macroglobulin (α(2)M) have been reported as the major inhibitors of plasma kallikrein in normal plasma, there is little quantitative support for this conclusion. Thus, we studied the inactivation of purified kallikrein in normal plasma, as well as in plasma...
Gardado en:
| Publicado en: | J Clin Invest |
|---|---|
| Principais autores: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Society for Clinical Investigation
1982
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC370996/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6173399/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI110470 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|